Dr Reddy's Laboratories Gets US FDA OK For Omeprazole
MUMBAI -(Dow Jones)- Dr. Reddy's Laboratories Ltd. (500124.BY) said Tuesday it has received approval from the U.S. Food and Drug Administration to sell Omeprazole tablets.
Omeprazole, the generic version of AstraZeneca PLC's (AZN) Prilosec, is used for the treatment of stomach ulcers and heartburn.
The first shipment of Omeprazole will begin early in the July-September quarter, the drug maker said in a filing with the Bombay Stock Exchange.
June 10, 2009